Sign In
Buy HBP
$10.70
+0 (+0%)
At Close: Aug 17, 2022
Helix BioPharma Corp. Announces CFO Appointment to Support Strategic Growth and Upcoming Milestones
04:30pm, Monday, 02'nd Jun 2025
2 June 2025 – TheNewswire - (Toronto, Ontario) – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage onco
May 20 , 2025 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage onco
Helix BioPharma Corp. (HBP.TO) Signs Capital Raising Agreement with Kerentech Consulting Ltd.
11:45am, Wednesday, 14'th May 2025
May 14, 2025 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage oncol
Helix BioPharma Corp. Appoints Dr. Thomas Mehrling as Chief Executive Officer to Drive Ambitious Clinical Development Plan
11:30am, Thursday, 10'th Apr 2025
April 10, 2025 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage onc
Helix BioPharma Corp. Announces Engagement of Independent Trading Group to Provide Market-Making Services
09:00am, Thursday, 03'rd Apr 2025
April 3, 2025 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage onco
March 18, 2025 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage onc
Helix BioPharma Corp. Announces Upcoming Poster Presentation at the 20th European Molecular Imaging Meeting in Bilbao, Spain
01:40pm, Tuesday, 11'th Mar 2025
March 11, 2025 – TheNewswire - Toronto, Ontario – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPCD” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage onc
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates LAX, ZWS, MGI, SAVE, HBP
12:33am, Wednesday, 13'th Apr 2022
NEW YORK , April 13, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breach
SHAREHOLDER ALERT: Weiss Law Reminds HBP, EMCF, CCHWF, and MGI Shareholders About Its Ongoing Investigations
05:16pm, Tuesday, 05'th Apr 2022
NEW YORK , April 5, 2022 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your righ
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Huttig Build
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Huttig Building Products, Inc. (NASDAQ: HBP) to Woodgrain Inc. for $10.70 per share
Huttig Building Products, Inc. (HBP) CEO Jon Vrabely on Q4 2021 Results - Earnings Call Transcript
08:06pm, Thursday, 03'rd Mar 2022 Seeking AlphaHuttig Building Products, Inc. (HBP) CEO Jon Vrabely on Q4 2021 Results - Earnings Call Transcript
03:06pm, Thursday, 03'rd Mar 2022
Huttig Building Products, Inc. (HBP) CEO Jon Vrabely on Q4 2021 Results - Earnings Call Transcript
Huttig Building Products GAAP EPS of $0.25, revenue of $230.4M
09:31pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
Huttig Building Products press release (NASDAQ:HBP): Q4 GAAP EPS of $0.25.Revenue of $230.4M (+24.8% Y/Y).
Huttig Building Products, Inc. Schedules Fourth Quarter 2021 Earnings Call
03:09pm, Tuesday, 15'th Feb 2022
ST. LOUIS, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Huttig Building Products (Nasdaq: HBP), one of the nation's largest wholesale distributors of millwork and specialty building products used principally in
